Biocon launches Hepatitis C drug in India
Biocon has introduced Cimivir - L drug for Hepatitis C in India. Company MD Kiran Mazumdar Shaw talks to ET Now about the prospects of this new drug and the financial implications for the company.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
